The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions, providing comprehensive transaction coverage from 1991 to the present.
Roche Professional Diagnostics (RPD; part of Roche) is paying €11mm ($15mm) up front in cash for privately held Verum Diagnostica GMBH (laboratory coagulation analysis), which is owned by German medtech company Dynabyte Informationssysteme GMBH. Verum could also receive €2mm in earn-outs based on its performance. (Dec.)
Verum was founded last year as a consolidation of all of Dynabyte’s diagnostic assets, most notably Multiplate, which was launched...